参考文献

参考文献

［1］Albero A，Lopez J E，Torres A，et al.Effectiveness of chemotherapy in advanced differentiated thyroid cancer：a systematic review［J］.Endocr Relat Cancer，2016，23（2）：R71-R84.

［2］Armstrong M J，Yang H，Yip L，et al.PAX8/PPARγ rearrangement in thyroid nodules predicts follicular-pattern carcinomas，in particular the encapsulated follicular variant of papillary carcinoma［J］.Thyroid，2014，24（9）：1369-1374.

［3］Aurangabadkar H U，Palle L，Ali Z.Tumour thrombosis and patterns of fluorine-18 fluorodeoxyglucose uptake：a pictorial review［J］.Nucl Med Commun，2013，34（7）：627-637.

［4］Besic N，Auersperg M，Gazic B，et al.Neoadjuvant chemotherapy in 29 patients with locally advanced follicular or Hürthle cell thyroid carcinoma：a phase 2 study［J］.Thyroid，2012，22（22）：131-137.

［5］Chang W C，Chen J Y，Lee C H，et al.Expression of decoy receptor 3 in diffuse sclerosing variant of papillary thyroid carcinoma：correlation with M2 macrophage differentiation and lymphatic invasion［J］.Thyroid，2013，23（6）：720-726.

［6］Chen L，Shen Y，Wu X，et al.Anatomic and metabolic imaging of venous thromboembolism mimicking thyroid carcinoma extension［J］.J Thromb Thrombolysis，2010，29（3）：358-360.

［7］Falanga A，Marchetti M，Russo L.The mechanisms of cancer-associated thrombosis［J］.Thromb Res，2015，135（Suppl 1：）：S8-S11.

［8］Gharib H，Papini E，Paschke R，et al.American Association of Clinical Endocrinologists，Associazione Medici Endocrinologi，and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules［J］.J Endocrinol Invest，2010，33（5）：287-291.

［9］He X，Li D，Hu C，et al.Outcome after intensity modulated radiotherapy for anaplastic thyroid carcinoma［J］.BMC Cancer，2014，14（1）：235.

［10］Hyer S L，Dandekar P，Newbold K，et al.Thyroid cancer causing obstruction of the great veins in the neck［J］.World J Surg Oncol，2008，6：36.

［11］Jr W S，Asa S L，Dralle H，et al.Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma［J］.Thyroid，2015，25（6）：567-610.

［12］Kawano F，Tomita M，Tanaka H，et al.Thyroid carcinoma with extensive tumor thrombus in the superior vena cava：A case report［J］.Int J Surg Case Rep，2016，29：25-29.

［13］Kobayashi K，Hirokawa M，Yabuta T，et al.Tumor thrombus of thyroid malignancies in veins：importance of detection by ultrasonography［J］.Thyroid，2011，21（5）：527-531.

［14］Landa I，Ibrahimpasic T，Boucai L，et al.Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers［J］.J Clinic Invest，2016，126（3）：1052-1066.

［15］Manfredi G I，Dicitore A，Gaudenzi G，et al.PI3K/Akt/mTOR signaling in medullary thyroid cancer：a promising molecular target for cancer therapy［J］.Endocrine，2015，48（2）：363.(https://www.daowen.com)

［16］Manik G，Jose J，Hygriv Rao B.Follicular thyroid carcinoma with tumour thrombus extending into superior vena cava and right atrium—a case report［J］.Indian Heart J，2016，68（Suppl 2）：S146-S147.

［17］Marcy P Y，Thariat J，Chevenet C，et al.Jugular vein invasion diagnosis and prognosis in thyroid carcinomas［J］.Pol J Radiol，2016，81：268-269.

［18］Mould R C，van Vloten J P，Awk A Y，et al.Immune response in the thyroid cancer microenvironment：making immunotherapy a possible mission［J］.Endocr Relat Cancer，2017，24（12）：T311-T329.

［19］Nakashima T，Nakashima A，Murakami D，et al.Follicular carcinoma of the thyroid with massive invasion into the cervical and mediastinum great veins：our own experience and literature review［J］.Laryngoscope，2012，122（12）：2855-2857.

［20］Naoum G E，Morkos M，Kim B，et al.Novel targeted therapies and immunotherapy for advanced thyroid cancers［J］.Mol Cancer，2018，17（1）：51.

［21］Onoda N，Nakamura M，Hosono M，et al.Successful surgical treatment of advanced follicular thyroid carcinoma with tumor thrombus infiltrating the superior vena cava：report of a case［J］.Surg Today，2012，42（2）：185-190.

［22］Salaun P Y，Bodet-Milin C，Frampas E，et al.Toxicity and efficacy of combined radioimmunotherapy and bevacizumab in a mouse model of medullary thyroid carcinoma［J］.Cancer，2010，116（S4）：1053-1058.

［23］Sugitani I，Miyauchi A，Sugino K，et al.Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma：ATC Research Consortium of Japan cohort study of 677 patients［J］.World J Surg，2012，36（6）：1247-1254.

［24］Takahashi M，Ritz J，Cooper G M.Activation of a novel human transforming gene，ret，by DNA rearrangement［J］.Cell，1985，42（2）：581-588.

［25］Wakasaki T，Kiyohara H，Omori H，et al.Massive internal jugular vein tumor thrombus derived from squamous cell carcinoma of the head and neck：two case reports［J］.Oral Maxillofac Surg，2017，21（1）：69-74.

［26］Yamagami Y，Tori M，Sakaki M，et al.Thyroid carcinoma with extensive tumor thrombus in the atrium［J］.Gen Thorac Cardiovasc Surg，2008，56（11）：555-558.

［27］Ying C H，Shellenberger T D，Williams M D，et al.High rate of BRAF and RET/PTC dual mutations associated with recurrent papillary thyroid carcinoma［J］.Clin Cancer Res，2009，15（2）：485-491.

［28］Yoshimura M，Kawamoto A，Nakasone K，et al.Gallium-67 accumulation to the tumor thrombus in anaplastic thyroid cancer［J］.Ann Nucl Med，2003，17（8）：689-691.

［29］韩志江，包凌云，陈文辉.甲状腺及甲状旁腺病变影像比较诊断学［M］.北京：人民卫生出版社，2016.